Publications
173
Citations
2,719
Est. group size
~1
Recurring co-author estimate
Active years
27
Publishing since 2000
Peter P. Stanich's research focuses on hereditary and inherited gastrointestinal cancer syndromes, including familial adenomatous polyposis, Lynch syndrome, PTEN hamartoma tumor syndrome, and CDH1-related gastric cancer risk. Much of the work involves clinical trials of chemoprevention drugs (like rapamycin/sirolimus) to reduce polyp growth, as well as studies on screening, surveillance, and management guidelines for patients at high genetic risk of colorectal and gastric cancers. This work is relevant to students interested in clinical/translational gastroenterology and cancer prevention research.
Publication output has been relatively steady over the past decade, with a peak around 2021-2022, a dip in 2023-2024, and a rebound in 2025.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- ONC201 for chemoprevention of colorectal cancer.
Journal of Clinical Oncology · 2026
- Clinicopathological Factors Associated with Gastric Signet Ring Cell Carcinoma in <i>CDH1</i> Pathogenic Variant Carriers: Report from the GASTRIC Consortium
medRxiv · 2026
- Phase II Trial of Encapsulated Rapamycin to Reduce Polyp Burden Associated with Familial Adenomatous Polyposis
Clinical Cancer Research · 2026
- Sirolimus for Colon Polyposis in PTEN Hamartoma Tumor Syndrome
Clinical and Translational Gastroenterology · 2025
- Strategic Plan of the Collaborative Group of the Americas on Inherited Gastrointestinal Cancer (CGA-IGC): A practical roadmap to move the hereditary gastrointestinal cancer field forward
Familial Cancer · 2025
- Tu1139: SIROLIMUS FOR COLON POLYPOSIS IN PTEN HAMARTOMA TUMOR SYNDROME
Gastroenterology · 2025
- 600: POST OPERATIVE OUTCOMES AND COMPLICATIONS OF CDH1 CARRIERS UNDERGOING PROPHYLACTIC GASTRECTOMY– RESULTS FROM THE GASTRIC CONSORTIUM
Gastroenterology · 2025
- Colorectal polyp count discrepancies and their impact on colonoscopy surveillance interval decisions: a retrospective analysis of 1293 specimens
American Journal of Clinical Pathology · 2025
- 1143 PHASE IIA TRIAL OF ENCAPSULATED RAPAMYCIN (ERAPA) IN PATIENTS WITH FAMILIAL ADENOMATOUS POLYPOSIS TO REDUCE INTESTINAL POLYP BURDEN: 6 MONTH INTERIM RESULTS
Gastroenterology · 2024
- Rebranding Colonic Polyposis of Unknown Etiology
Journal of Clinical Gastroenterology · 2023
- International Delphi consensus guidelines for follow-up after prophylactic total gastrectomy: the Life after Prophylactic Total Gastrectomy (LAP-TG) study
Gastric Cancer · 2022
- Yield of upper gastrointestinal screening in colonic adenomatous polyposis of unknown etiology: a multicenter study
Endoscopy International Open · 2022
- Colorectal Neoplasia in CDH1 Pathogenic Variant Carriers: A Multicenter Analysis
The American Journal of Gastroenterology · 2022
- Endoscopic Surveillance in Patients with the Highest Risk of Gastric Cancer: Challenges and Solutions
Cancer Management and Research · 2022
- Accurate Determination of Colorectal Polyp Counts Is Not Mission Impossible for Pathologists and Is Essential for Surveillance Interval Decision-Making: A Review of 1294 Specimens
American Journal of Clinical Pathology · 2022
- The American Journal of Gastroenterology×28
- Gastroenterology×17
- Familial Cancer×6
- Clinical Gastroenterology and Hepatology×5
- Gastrointestinal Endoscopy×5
- Douglas K. Rex
Medicine · Indiana University
- Thomas F. Imperiale
Medicine · Indiana University
- Charles J. Kahi
Medicine · Indiana University
- Jennifer K. Maratt
Medicine · Indiana University
- Douglas K. Rex
Medicine · Indiana University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile